Midea to become new FC Barcelona Main Partner
World's No. 1 smart home appliance brand signs 5-season agreement to appear on…
India’s Gaming Reset: New Law Sparks a Turning Point for the Industry, Says Redseer Strategy Consultants
BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- With over 500 million digital…
Coloplast A/S – Announcement no. 07/2025 – Coloplast announces new financial ambition towards 2030
In relation to the launch of Coloplast’s new 5-year strategy, Impact4, the company…
NEXEN TIRE Expands Global Footprint with New Hubs in Europe, Latin America, and the Middle East
SEOUL, South Korea – September 1, 2025 – NEXEN TIRE, a leading…
Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches
ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a…
Zhejiang-based GNMI Expands Overseas: Hangzhou Becomes a New Starting Point for the China-German Industrial Synergies
Hangzhou, China, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of…
GameChange Solar expands into New Zealand with Bright Fern Energy’s Dannevirke Solar Farm
SYDNEY, Sept. 2, 2025 /PRNewswire/ -- GameChange Solar, a leading global supplier…
Tescan Unveils New Global Brand Platform “The Art of Discovery” with APAC Rollout at SEMICON Taiwan
KARLSRUHE, Germany, BRNO, Czech Republic and TAIPEI, Sept. 1, 2025 /PRNewswire/ -- Tescan Group…
The New Kia Stonic unveiled with elevated design and technology
The new Kia Stonic significantly enhanced inside and out with a confident,…
New REDUCE-IT Analyses Presented at ESC 2025 Include Data Showing VASCEPA/VAZKEPA (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl…
